They said it was “safe and effective”; covid vaccine contracts with the South African government show it was a lie

Featured image: South African President Cyril Ramaphosa receives the Johnson & Johnson covid injection in South Africa on 17 February 2021. Source: Sowetan Live
In August, a South African Court ordered the National Department of Health (“NDOH”) to release covid vaccine contracts and other related documents. At the beginning of September, the first batch of documents was released.
On Thursday 17 August 2023, the Pretoria High Court ruled in favour of the Health Justice Initiative’s (“HJI’s”) bid to compel the NDOH to provide access to all covid “vaccine” procurement contracts and other documents. The Court ordered that all covid vaccine contracts (“Part 1”) and negotiation-related documents (“Part 2”) must be made public within 10 court days of the Judgment.
On 1 September, HJI issued a press statement saying that NDOH had handed documents for Part 1 to HJI’s legal team. NDOH has undertaken to share the remainder of the documents, Part 2, which it was ordered to disclose, and in agreement with HJI, by no later than 29 September 2023.
On 5 September, HJI held a press briefing after which they uploaded the Part 1 documents to their website HERE. The Part 1 documents comprise:
* COVAX Facility/Gavi Alliance – Committed Purchase Agreement (dated 11 December 2020).
* Janssen Pharmaceutica – Advance Purchase Agreement (26 February 2021).
* Janssen Pharmaceutica – Advance Purchase Agreement, Additional Doses (_ April 2021).
* Janssen Pharmaceutica – Term Sheet (19 November 2020).
* Pfizer – Manufacturing and Supply Agreement (30 March 2021).
* Pfizer – Amendment to Manufacturing and Supply Agreement (4 June 2021).
* Pfizer – Binding Term Sheet.
* Serum Institute of India – Vaccine Purchase Agreement (18 January 2021).
* Serum Institute of India – Term Sheet (7 January 2021).
It is worth noting that the HJI was launched in July 2020 in South Africa “to advocate for a more inclusive, equitable public health system, locally and globally, both during and beyond the pandemic.” It was established using all the verbiage of the Globalist agenda.
The founder of HJI is Fatima Hassan, a South African human rights lawyer and social justice activist. She is the former executive director of the Open Society Foundation of South Africa, founded by infamous globalist George Soros.
We can safely assume that HJI is under the influence, if not the control, of the Globalists.
Further reading: How the British Invented George Soros, Lew Rockwell, 19 June 2021
Pfizer Covid Vaccine Contract
In the March 2021 manufacturing and supply agreement (“vaccine contract”) between Pfizer and NDOH, there is a paragraph that admits the safety and the efficacy of Pfizer’s covid injection were unknown:
5.1 Purchaser Acknowledgement.
Purchaser acknowledges that the Vaccine and materials related to the Vaccine, and their components and constituent materials are being rapidly developed due to the emergency circumstances of the COVID-19 pandemic and will continue to be studied after provision of the Vaccine to Purchaser under this Agreement. Purchaser further acknowledges that the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects of the Vaccine that are not currently known. Further, to the extent applicable, Purchaser acknowledges that the Product shall not be serialized. [Emphasis our own.]
Janssen Covid Vaccine Contract
The NDOH contract with Janssen shows a similar lack of confidence in the “safety and efficacy” of its covid injection.
The Janssen covid injection was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, a subsidiary of American company Johnson & Johnson (“J&J”).
The South African government signed two agreements with Janssen. The first was an ‘Advance Purchase Agreement’ dated 26 February 2021, to secure 11 million doses, followed by a second for the supply of additional doses on an unspecified date in April 2021.
Additional Vaccine Volume
5.2 The Government Purchaser acknowledges and agrees that:
(b) the final total dosage and administration schedule of COVID Vaccine required to protect one (I) individual against SARS-CoV-2/COVID-19 has not been determined as of the Effective Date [xx April 2021] and, without prejudice to clause 5.2(c), shall be determined solely by Janssen based on data generated in ongoing clinical trials; Janssen shall be entitled to unilaterally adjust the definition of Vaccine Dose set out in this Agreement after the Effective Date based on data generated as part of its ongoing clinical trials. [pg.12]
(c) Janssen provides no warranty that a Vaccine Dose will be sufficient to protect one (I) individual against COVID-19, or that the COVID Vaccine is safe or efficacious [pg.12]
13.4 … Janssen disclaims, to the fullest extent permitted by Law, all warranties … relating to the sufficiency of a single Vaccine Dose to protect one (I) individual against SARS-Co V-2/COVID-l 9 or the safety or effectiveness of the COVID Vaccine. [pg. 22] [Emphasis our own.]
Notably, on the ‘Additional Doses’ purchase agreement’s title page is an EMEA document reference. EMEA refers to Europe, the Middle East, and Africa, a geographical grouping used by global corporations to define regional business activity. Does this mean that Janssen used the same contract for all countries in the EMEA region?

Kommentare